18.10.2018 • News

Linde, Praxair Work with US FTC on Merger

Linde, Praxair Work with US FTC on Merger (c) Linde
Linde, Praxair Work with US FTC on Merger (c) Linde

As the Oct. 24 deadline for the Linde/Praxair merger edges closer, the German industrial gas maker said the companies has “aligned” with Federal Trade Commission (FTC) staff on Oct. 1 regarding the required asset sales as part of the US antitrust review.

Linde also confirmed that the companies have submitted a remedy package to the FTC commissioners for their decision. It is not clear when the commissioners will vote on the merger but the deal’s conditions require that the FTC gives clearance by the end of Oct. 24.

The merger is also subject to the “timely receipt” of buyer approval by the European Commission.

In September, a Bloomberg news agency report said Linde and Praxair were looking to sell additional assets worth around $200 million to Messer Group and CVC Capital Partners to allay antitrust concerns. The assets were said to comprise three air separation plants, a carbon dioxide plant, a liquid argon contract and two depots.

Messer and CVC, through their joint venture MG Industries, had previously already agreed to buy the majority of Linde’s business in North America along with certain activities in South America.

Praxair has also already agreed to sell its European gases operations to Japan’s Taiyo Nippon Sanso for €5 billion.

Speaking to a US-based trade journal, a Jefferies analyst said he remains optimistic that FTC approval could be reached before the deadline, adding that the European Commission’s buyer approval should also be “manageable” by Oct 24.

The other outstanding antitrust approvals have now been received, notably from China on Sept. 30 and South Korea on Oct. 8.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.